Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents

Biotechnology and Bioengineering

Volumn 108, Issue 2, 2011, Pages 243-252

  Reukov, Vladimir ^a   Maximov, Victor ^a   Vertegel, Alexey ^a  

^a South   (United States)

Author keywords

Conjugate; Enzymes; Glutamate; Nanoparticle; Neuroprotection; Poly(butyl cyanoacrylate); Secondary spinal cord injury; Superoxide dismutase

Indexed keywords

BUTYL CYANOACRYLATE; CONJUGATE; GLUTAMATE; NEUROPROTECTION; SPINAL CORD INJURY; SUPER OXIDE DISMUTASE;

CATALYSTS; CELL CULTURE; DEXTRAN; DOSIMETRY; DRUG DELIVERY; ENZYMES; GLUCOSE; NANOPARTICLES; OXYGEN; PATIENT REHABILITATION; PLANTS (BOTANY);

ANTIBODIES;

DEXTRAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NANOPARTICLE; NEUROPROTECTIVE AGENT; POLY(BUTYL CYANOACRYLATE); POLYCLONAL ANTIBODY; POLYMER; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONJUGATE; CONTROLLED STUDY; COVALENT BOND; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; IN VITRO STUDY; NEWBORN; NONHUMAN; PARTICLE SIZE; PH; POLYMERIZATION; RAT; SPINAL CORD INJURY;

ANIMALS; ANTIBODIES; CELLS, CULTURED; DRUG CARRIERS; ENBUCRILATE; NANOPARTICLES; NEURONS; NEUROPROTECTIVE AGENTS; PROTEIN BINDING; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 78650217902     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22958     Document Type: Article

References (30)

1. Begley DJ. 2004. Delivery of therapeutic agents to the central nervous system: The problems and the possibilities. Pharmacol Therapeut 104(1): 29-45.
2. Chan WCW. 2006. Bionanotechnology progress and advances. Biol Blood Marrow Transplant 12(1): 87-91.
3. Connolly S, Cobbe S, Fitzmaurice D. 2001. Effects of ligand-receptor geometry and stoichiometry on protein-induced aggregation of biotin-modified colloidal gold. J Phys Chem B 105(11): 2222-2226.
4. Costanzo PJ, Patten TE, Seery TAP. 2004. Protein-ligand mediated aggregation of nanoparticles: A study of synthesis and assembly mechanism. Chem Mater 16(9): 1775-1785.
5. DiDonato M, Craig L, Huff ME, Thayer MM, Cardoso RMF, Kassmann CJ, Lo TP, Bruns CK, Powers ET, Kelly JW, Getzoff ED, Tainer JA. 2003. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J Mol Biol 332(3): 601-615.
6. Dugan LL, Gabrielsen JK, et al. 1996. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 3(2): 129-135.
7. Dugan, LL, Turetsky DM, et al. 1997. Carboxyfullerenes as neuroprotective agents (vol. 94, p. 9434, 1997). Proc Natl Acad Sci USA 94(22): 12241-12241.
8. Dugan LL, Lovett EG, et al. 2001. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord 7(3): 243-246.
9. Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM. 2009. Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem 284(11): 6972-6981.
10. Jin H, Chen WQ, Tang XW, Chiang LY, Yang CY, Schloss JV, Wu JY. 2000. Polyhydroxylated C-60, fullerenols, as glutamate receptor antagonists and neuroprotective agents. J Neurosci Res 62(4): 600-607.
11. Kondo A, Murakami F, Kawagoe M, Higashitani K. 1993. Kinetic and circular-dichroism studies of enzymes adsorbed on ultrafine silica particles. Appl Microbiol Biotechnol 39(6): 726-731.
12. Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47(1): 65-81.
13. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. 2002. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10(4): 317-325.
14. Kurakhmaeva KB, Djindjikhashvili IA, Petrov VE, Balabanyan VU, Voronina TA, Trofimov SS, Kreuter J, Gelperina S, Begley D, Alyautdin RN. 2009. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J Drug Target 17(8): 564-574.
15. Lewin M, Carleso N, Tung C-H, Tang X-W, Cory D, Scadden DT, Weissleder R. 2000. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of Rrogenitor cells. Nat Biotechnol 18: 410.
16. Lockman PR, Mumper RJ, Khan MA, Allen DD. 2002. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 28(1): 1-113.
17. Maximov VD, Reukov VV, Barry JN, Cochrane C, Vertegel AA. 2010. Protein-nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia. Nanotechnology 21(26): 9.
18. Reddy MK, Labhasetwar V. 2009. Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury. FASEB J 23(5): 1384-1395.
19. Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V. 2008. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl Biochem Biotechnol 151(2-3): 565-577.
20. Richards DC, Richards JS, Bier CJ. 1972. Two crystal forms of bovine superoxide dismutase. J Biol Chem 247(19): 6368.
21. Schrock AK, Schuster GB. 1984. Photochemistry of phenyl azide: Chemical properties of the transient intermediates. J Am Chem Soc 106(18): 5228-5234.
22. Sergeev BM, Kiryukhin MV, Rubtsova MY, Prusov AN. 2003. Synthesis of protein A conjugates with silver nanoparticles. Colloid J 65(5): 636-638.
23. Sommerfeld P, Sabel BA, Schroeder U. 2000. Long-term stability of PBCA nanoparticle suspensions. J Microencapsul 17(1): 69-79.
24. Torchilin VP, Rammohan R, Weissig V, Leuchenko TS. 2000. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci 98: 8786.
25. Vertegel AA, Shang W, Dordick JS, Siegel RW. 2005. Protein-directed self-assembly of gold nanoparticles. Mater Res Soc Symp Proc Paper #: 0901-Ra10-06 (2006).
26. Vinogradov SV, Batrakova EV, Kabanov AV. 2004. Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem 15(1): 50-60.
27. Webb K, Budko E, Neuberger TJ, Chen S, Schachner M, Tresco PA. 2001. Substrate-bound human recombinant L1 selectively promotes neuronal attachment and outgrowth in the presence of astrocytes and fibroblasts. Biomaterials 22(10): 1017-1028.
28. Westermeier R, Marouga R. 2005. Protein detection methods in proteomics research. Biosci Rep 25(1-2): 19-32.
29. Wohlgemuth M, Machtle W, Mayer C. 2000. Improved preparation and physical studies of polybutylcyanoacrylate nanocapsules. J Microencapsul 17(4): 437-448.
30. Yurko Y, Maximov V, Andreozzi E, Thompson GL, Vertegel AA. 2009. Design of biomedical nanodevices for dissolution of blood clots. Mater Sci Eng C (Biomimet Supramol Syst) 29(3): 737-741.